BioSpace News Archive

Business

CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today reported second quarter 2023 financial results and provided a business update.

August 8, 2023
·
14 min read
Pharm Country

KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference

KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”) today announced that the Company will participate in the Canaccord Genuity 43rd Annual Growth Conference on August 10, 2023.

August 8, 2023
·
1 min read
Business

Model N Announces Third Quarter Fiscal Year 2023 Financial Results

Model N, Inc., the leader in cloud revenue management solutions, announced financial results for the third quarter of fiscal year 2023 ended June 30, 2023.

August 8, 2023
·
22 min read
Business

Movano Inc. to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

Movano Inc. (NASDAQ:MOVE) dba Movano Health, a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it will report second quarter 2023 financial and operating results on Monday, August 14, 2023.

August 8, 2023
·
2 min read
Business

Orthofix Reports Second Quarter 2023 Results and Raises Revenue and Adjusted EBITDA Guidance

Orthofix Medical Inc. reported its financial results for the quarter ended June 30, 2023.

August 8, 2023
·
15 min read
Business

Emergent BioSolutions Reports Financial Results for Second Quarter 2023

Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2023. It also announced strategic steps to reduce investment in and de-emphasize focus on growth in its CDMO business.

August 8, 2023
·
35 min read
Business

Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023

Vistagen (NASDAQ: VTGN) today announced it will host a conference call and webcast on Thursday, August 10, 2023, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and report results for its fiscal year 2024 first quarter ended June 30, 2023.

August 8, 2023
·
2 min read
Biotech Beach

New Thermo Fisher Scientific™ TSG Series Refrigerators Reduce Waste and Save Energy

Thermo Fisher Scientific, the world leader in serving science, announced a new line of Thermo Scientific TM TSG Series Refrigerators to ensure the safe storage of critical vaccines and pharmaceuticals for laboratory, pharmacy and clinical* environments.

August 8, 2023
·
3 min read
Business

Everest Medicines to Announce First Half 2023 Financial Results on August 24, 2023

Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”) today announced that it will report financial results for the first half of 2023 ended June 30, 2023 and provide a business update on August 24, 2023.

August 8, 2023
·
3 min read
Drug Development

Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe

Biophytis SA, announced that it has received a positive opinion from Belgian authorities to conduct its SARA-31 program, which will be the first phase 3 study ever launched in sarcopenia.

August 8, 2023
·
5 min read